According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$1.67 Billion. In 2023 the company made a revenue of HK$1.00 Billion an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | HK$1.68 B | 66.85% |
2023 | HK$1.00 B | |
2022 | N/A | |
2021 | N/A |